How to Know If You’re a Candidate for Hormone Therapy
One of the most common questions women ask when they start researching hormone therapy is whether it’s even an option for them. The answer, for most healthy women in perimenopause or early menopause, is that it’s worth a real conversation. But because hormone therapy involves an individualized risk-benefit assessment, the only way to know for certain is to go through that evaluation with a provider who takes the full picture into account.
This article explains what that evaluation actually looks like — the questions a physician asks, the factors that affect candidacy, and what it means to have care that’s genuinely tailored to you.
Who hormone therapy is generally appropriate for
Hormone therapy is most prescribed for women who are in perimenopause or within 10 years of their last menstrual period, are under 60, are experiencing symptoms that are meaningfully affecting their quality of life, and do not have specific contraindications that would make hormone therapy inadvisable.
This describes a wide population of women. Most women who are experiencing the symptoms of perimenopause and menopause — hot flashes, sleep disruption, mood changes, brain fog, weight shifts, low libido, vaginal dryness — are candidates for a real conversation about hormone therapy, even if they’re not certain it’s the right choice for them.
The conversation is the starting point. The evaluation that follows determines the path.
What a thorough evaluation covers
A good hormone therapy evaluation is not a quick checklist. It’s a comprehensive review of who you are medically, what you’re experiencing, and what you’re trying to achieve. Here’s what it should include.
Your full symptom picture. Not just the symptom you led with, but all of them. Sleep, mood, cognitive function, energy, cycle changes, physical symptoms, sexual health. The complete picture informs both the diagnosis and the protocol.
Your personal health history. This includes cardiovascular history, history of blood clots, liver function, migraine history, and any prior cancer diagnoses — particularly hormone-sensitive cancers like certain types of breast cancer and endometrial cancer. These factors affect both candidacy and the specific approach.
Your family health history. A family history of breast cancer, cardiovascular disease, or osteoporosis is relevant context for the risk-benefit conversation. It doesn’t automatically disqualify anyone, but it shapes the evaluation.
Your current medications and supplements. Some medications interact with hormone therapy in ways that matter for dosing and safety. A full medication review is part of a responsible evaluation.
Your goals. Are you primarily seeking symptom relief? Long-term health support? Both? Understanding what you’re trying to achieve helps your provider recommend an approach that actually serves your priorities.
Factors that affect the risk-benefit calculation
Hormone therapy is not a single intervention with a single risk profile. The type of hormones used, the delivery method, the dose, and the timing of initiation all affect the risk-benefit picture — as does your individual health history.
Timing matters significantly. There is strong evidence that hormone therapy initiated close to the onset of menopause — generally within 10 years of the last period or before age 60 — carries a more favorable risk profile than therapy initiated later. Women who start hormone therapy in this window appear to benefit from cardiovascular and cognitive protective effects that are less pronounced when therapy starts a decade or more after menopause. This is sometimes called the window of opportunity, and it’s a reason to have the conversation sooner rather than waiting until symptoms become severe.
Delivery method affects certain risks. Transdermal estrogen — delivered through the skin via a patch rather than taken orally — has a lower associated risk of blood clots than oral estrogen. For women with certain cardiovascular risk factors or a history of migraines, the patch is often the preferred option. Your provider will factor this into their recommendation.
The type of progesterone matters. Bioidentical progesterone, which is what Ivim Health uses in its hormone health program, has a different risk profile than the synthetic progestin used in the original Women’s Health Initiative study that generated widespread fear about hormone therapy. This distinction is clinically meaningful and often not adequately explained to women who are worried about what they’ve heard.
Personal cancer history requires careful evaluation. Women with a history of hormone-sensitive breast cancer are generally not candidates for systemic hormone therapy, though this depends on the specific type of cancer, treatment received, and how much time has passed.
Who is generally not a candidate
Absolute contraindications to hormone therapy include active or recent hormone-sensitive breast cancer, active liver disease, unexplained vaginal bleeding, a personal history of blood clots in certain contexts, and active cardiovascular disease including recent heart attack or stroke. These are situations where the risks of hormone therapy outweigh the benefits for most women.
Relative contraindications — factors that require careful weighing rather than automatic exclusion — include controlled cardiovascular risk factors, a family history of hormone-sensitive cancers, gallbladder disease, and certain migraine patterns. Women in these categories are not automatically excluded from hormone therapy, but the evaluation needs to be thorough and the approach may need to be modified.
It is worth being direct about something: the list of women who are not candidates for hormone therapy is shorter than the fear around hormone therapy suggests. Many women who have been told hormone therapy isn’tfor them — or who have assumed it isn’t — have not had a current, evidence-based evaluation. The science has changed significantly since the early 2000s, and the clinical guidance has changed with it.
Questions worth asking your provider
If you are going into an evaluation for hormone therapy, these questions will help you get the most out of the conversation.
What specific factors in my health history are most relevant to whether hormone therapy is appropriate for me? If you’re recommending a particular delivery method or formulation, why that one over the alternatives? What side effects should I watch for, and what should I do if I experience them? How will we know if it’s working? What does the process look like for adjusting my protocol if needed? How long would I stay on hormone therapy, and how would that decision be made?
A provider who answers these questions clearly and completely is giving you the foundation for informed decision-making. That’s what this process should produce.
What happens after the evaluation
If you are a candidate for hormone therapy, the evaluation leads to a protocol recommendation — specific medications, delivery methods, and dosing tailored to your symptom picture and health history. That recommendation should come with a clear explanation of the reasoning behind it.
From there, the process is iterative. Your starting dose is not necessarily your permanent dose. As you respond to the protocol, your provider adjusts based on what’s working and what isn’t. Follow-up access to your provider is not optional — it’s how good hormone care actually functions.
If the initial evaluation determines that you are not a candidate, or that hormone therapy is not the right fit for your goals, that conversation should include a clear explanation of why and what alternatives exist. Not a candidate for systemic hormone therapy does not mean not a candidate for any support — there are non-hormonal options for specific symptoms, and a thorough provider will walk you through them.
The starting point
The only way to know whether hormone therapy is right for you is to go through a real evaluation with a provider who is current on the evidence and invested in understanding your specific picture. A conversation informed by current science, your full health history, and your actual goals is what makes the difference between a generic answer and a real one.
If you’re ready to find out where you stand, start with a hormone assessment at https://www.ivimhealth.com/womens-hormone-health/.
Disclaimer:
Medical Advice: This content is for informational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider regarding your health needs, diagnosis, and medication management.
